Birdwatch Archive

Birdwatch Note

2024-03-24 01:35:38 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING

投稿主は日常的に「 抗がん剤は癌に効果が無い」と投稿していますが、本ポストでは抗がん作用があるとされる別用途の薬を推奨している事から論理的矛盾を抱えている人物である事に注意してください‬ ‪また、「フェンベンダゾールで癌が治った」という情報の発信元であるジョー・ティッペンズ氏は、その証拠として掲げていた「自身が癌に罹患していた際のCTスキャン」が別人の物である事が発覚しています‬ ‪彼は抗がん剤の新薬の臨床試験に参加しており単体で癌が治ったと確認する事は不可能です‬ ‪https://www.newsweekjapan.jp/stories/technology/2019/12/post-13548_2.php‬ ‪副作用で亡くなった方もいるため服薬には慎重になってください‬ ‪https://www.koreabiomed.com/news/articleView.html?idxno=6835‬

Written by 0996DBAA9BC40C8DD48B11A482E71EA98944EC637DA17D557B4A920DB0B75707
Participant Details

Original Tweet

Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1771300760669815066

Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.

All Information

  • ID - 1771712444815270396
  • noteId - 1771712444815270396
  • participantId -
  • noteAuthorParticipantId - 0996DBAA9BC40C8DD48B11A482E71EA98944EC637DA17D557B4A920DB0B75707 Participant Details
  • createdAtMillis - 1711244138327
  • tweetId - 1771300760669815066
  • classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
  • believable -
  • harmful -
  • validationDifficulty -
  • misleadingOther - 0
  • misleadingFactualError - 1
  • misleadingManipulatedMedia - 0
  • misleadingOutdatedInformation - 1
  • misleadingMissingImportantContext - 1
  • misleadingUnverifiedClaimAsFact - 1
  • misleadingSatire - 0
  • notMisleadingOther - 0
  • notMisleadingFactuallyCorrect - 0
  • notMisleadingOutdatedButNotWhenWritten - 0
  • notMisleadingClearlySatire - 0
  • notMisleadingPersonalOpinion - 0
  • trustworthySources - 1
  • summary
    • 投稿主は日常的に「 抗がん剤は癌に効果が無い」と投稿していますが、本ポストでは抗がん作用があるとされる別用途の薬を推奨している事から論理的矛盾を抱えている人物である事に注意してください‬ ‪また、「フェンベンダゾールで癌が治った」という情報の発信元であるジョー・ティッペンズ氏は、その証拠として掲げていた「自身が癌に罹患していた際のCTスキャン」が別人の物である事が発覚しています‬ ‪彼は抗がん剤の新薬の臨床試験に参加しており単体で癌が治ったと確認する事は不可能です‬ ‪https://www.newsweekjapan.jp/stories/technology/2019/12/post-13548_2.php‬ ‪副作用で亡くなった方もいるため服薬には慎重になってください‬ ‪https://www.koreabiomed.com/news/articleView.html?idxno=6835‬

Note Status History

createdAt timestampMillisOfFirstNonNMRStatus firstNonNMRStatus timestampMillisOfCurrentStatus currentStatus timestampMillisOfLatestNonNMRStatus mostRecentNonNMRStatus participantId
2024-03-24 01:35:38 UTC
(1711244138327)
2024-03-24 10:59:17 UTC
(1711277957516)
CURRENTLY_RATED_HELPFUL 2024-03-25 02:05:07 UTC
(1711332307200)
CURRENTLY_RATED_HELPFUL 2024-03-24 10:59:17 UTC
(1711277957516)
CURRENTLY_RATED_HELPFUL

Note Ratings

rated at rated by
2024-03-24 19:44:11 -0500 Rating Details
2024-03-24 17:58:51 -0500 Rating Details
2024-03-24 17:04:22 -0500 Rating Details
2024-03-24 16:18:40 -0500 Rating Details
2024-03-24 15:00:05 -0500 Rating Details
2024-03-24 13:38:26 -0500 Rating Details
2024-03-24 05:53:52 -0500 Rating Details
2024-03-24 05:30:44 -0500 Rating Details
2024-03-24 05:00:23 -0500 Rating Details
2024-03-24 03:17:43 -0500 Rating Details
2024-03-24 02:06:36 -0500 Rating Details
2024-03-24 01:09:27 -0500 Rating Details
2024-03-24 01:05:11 -0500 Rating Details
2024-03-24 00:11:09 -0500 Rating Details
2024-03-23 23:54:25 -0500 Rating Details
2024-03-23 23:54:06 -0500 Rating Details
2024-03-23 23:46:20 -0500 Rating Details
2024-03-23 23:45:18 -0500 Rating Details
2024-03-23 23:35:23 -0500 Rating Details
2024-03-23 23:14:40 -0500 Rating Details
2024-03-25 13:45:39 -0500 Rating Details
2024-03-25 06:49:55 -0500 Rating Details
2024-03-25 05:31:23 -0500 Rating Details
2024-03-25 01:21:06 -0500 Rating Details
2024-03-24 22:56:01 -0500 Rating Details
2024-03-24 22:25:50 -0500 Rating Details
2024-03-24 22:19:47 -0500 Rating Details
2024-03-24 21:13:31 -0500 Rating Details
2024-03-24 20:13:02 -0500 Rating Details
2024-03-24 17:47:30 -0500 Rating Details
2024-03-24 17:09:09 -0500 Rating Details
2024-03-24 17:05:13 -0500 Rating Details
2024-03-24 17:01:50 -0500 Rating Details
2024-03-24 16:56:53 -0500 Rating Details
2024-03-24 16:24:46 -0500 Rating Details
2024-03-24 13:29:27 -0500 Rating Details
2024-03-24 06:43:06 -0500 Rating Details
2024-03-24 05:28:48 -0500 Rating Details
2024-03-24 04:17:59 -0500 Rating Details
2024-03-24 02:38:51 -0500 Rating Details
2024-03-24 02:16:24 -0500 Rating Details
2024-03-24 00:53:50 -0500 Rating Details
2024-03-24 00:53:34 -0500 Rating Details
2024-03-24 00:48:21 -0500 Rating Details
2024-03-24 00:22:34 -0500 Rating Details
2024-03-24 00:11:58 -0500 Rating Details
2024-03-23 23:51:46 -0500 Rating Details
2024-03-23 23:47:10 -0500 Rating Details
2024-03-23 23:42:33 -0500 Rating Details
2024-03-23 23:41:56 -0500 Rating Details
2024-03-23 23:41:23 -0500 Rating Details
2024-03-23 23:39:11 -0500 Rating Details
2024-03-23 23:39:07 -0500 Rating Details
2024-03-23 23:35:41 -0500 Rating Details
2024-03-23 23:34:39 -0500 Rating Details
2024-03-23 23:33:31 -0500 Rating Details
2024-03-23 23:28:10 -0500 Rating Details
2024-03-23 23:24:46 -0500 Rating Details
2024-03-23 23:24:17 -0500 Rating Details
2024-03-23 21:17:05 -0500 Rating Details
2024-03-24 22:39:41 -0500 Rating Details
2024-03-24 21:58:25 -0500 Rating Details
2024-03-24 20:56:32 -0500 Rating Details
2024-03-24 18:57:19 -0500 Rating Details
2024-03-24 17:47:18 -0500 Rating Details
2024-03-24 16:32:51 -0500 Rating Details
2024-03-24 16:22:10 -0500 Rating Details
2024-03-24 15:33:26 -0500 Rating Details
2024-03-24 14:05:56 -0500 Rating Details
2024-03-24 13:56:48 -0500 Rating Details
2024-03-24 13:35:58 -0500 Rating Details
2024-03-24 13:31:22 -0500 Rating Details
2024-03-24 10:49:53 -0500 Rating Details
2024-03-24 02:00:52 -0500 Rating Details
2024-03-24 01:42:49 -0500 Rating Details
2024-03-24 01:39:49 -0500 Rating Details
2024-03-24 01:19:10 -0500 Rating Details
2024-03-24 01:16:48 -0500 Rating Details
2024-03-24 00:30:34 -0500 Rating Details
2024-03-24 00:22:26 -0500 Rating Details
2024-03-24 00:01:05 -0500 Rating Details
2024-03-23 23:48:44 -0500 Rating Details
2024-03-23 23:47:59 -0500 Rating Details
2024-03-23 23:45:04 -0500 Rating Details
2024-03-23 23:39:52 -0500 Rating Details
2024-03-23 23:38:38 -0500 Rating Details
2024-03-23 23:38:36 -0500 Rating Details
2024-03-23 23:38:20 -0500 Rating Details
2024-03-23 23:37:18 -0500 Rating Details
2024-03-23 23:33:20 -0500 Rating Details
2024-03-23 23:31:29 -0500 Rating Details
2024-03-23 23:28:58 -0500 Rating Details
2024-03-23 22:44:23 -0500 Rating Details
2024-03-23 21:21:46 -0500 Rating Details
2024-03-23 20:46:10 -0500 Rating Details
2024-03-23 20:43:21 -0500 Rating Details
2024-03-27 06:12:55 -0500 Rating Details
2024-03-24 16:08:27 -0500 Rating Details